Prophylactic Gabapentin Results in Dramatic Reduction Of Narcotic Utilization In Head and Neck Cancer Patients Undergoing Radiotherapy
We report a retrospective single institution experience of the impact of prophylactic gabapentin (PG) on narcotic utilization in comparison to a historical non-PG control group.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: J.J. Mandia, H. Wang, R. Padmanabhan, Z. Ferguson, A.R. Chaurasia, A.K. Brennan, C. Solano, K. Skoczylas, P. Lee, J. Deeken, G.K. Bajaj Tags: Toxicity, Quality of Life, Survivorship, Costs of Care Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Carcinoma | Gabapentin | Head and Neck Cancer | History of Medicine | HNSCC | Neurontin | Pain | Pain Management | Physics | Radiology | Skin Cancer | Squamous Cell Carcinoma | Toxicology